Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease
The appropriate biomarkers for oxidative stress (OS) in patients with end stage renal disease (ESRD) are important in renal pathology. Patients (56) with ESRD were investigated (35 men and 21 women). Patients, with mean age of 45±17 years, defined education, specific HD duration and calculated body...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2015-12-01
|
Series: | Serbian Journal of Experimental and Clinical Research |
Online Access: | http://www.degruyter.com/view/j/sjecr.2015.16.issue-4/sjecr-2015-0037/sjecr-2015-0037.xml?format=INT |
id |
doaj-10d15308012a4124b71861af385fdaf7 |
---|---|
record_format |
Article |
spelling |
doaj-10d15308012a4124b71861af385fdaf72020-11-24T21:58:27ZengSciendoSerbian Journal of Experimental and Clinical Research 1820-86652335-075X2015-12-0116428729010.1515/sjecr-2015-0037sjecr-2015-0037Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal DiseaseDejanov Petar0Dejanova Beti1Medical Faculty in Skopje, Skopje, Former Yugoslav Republic of MacedoniaMedical Faculty in Skopje, Skopje, Former Yugoslav Republic of MacedoniaThe appropriate biomarkers for oxidative stress (OS) in patients with end stage renal disease (ESRD) are important in renal pathology. Patients (56) with ESRD were investigated (35 men and 21 women). Patients, with mean age of 45±17 years, defined education, specific HD duration and calculated body mass index (BMI), were exposed to a polysulphone type HD membrane for approximately 4 hours per HD session, 3 times per week. The control group was composed of 31 healthy volunteers. The total antioxidative capacity (TAC) and the antioxidative (AO) enzymes superoxide dismutase (SOD) and glutathione peroxidase (GPx), were assessed. Analyses included Randox Crumlin GB; lipid peroxidation (LP) using its end product, malonyldialdehyde (MDA) (fluorimetric); and a LDL-ox immunoassay (Biomedica gruppe, Vienna, Austria). The TAS was higher in ESRD patients before HD (1.63±0.1 mmol/L) compared to the control group (1.23±0.03 mmol/L).http://www.degruyter.com/view/j/sjecr.2015.16.issue-4/sjecr-2015-0037/sjecr-2015-0037.xml?format=INT |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Dejanov Petar Dejanova Beti |
spellingShingle |
Dejanov Petar Dejanova Beti Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease Serbian Journal of Experimental and Clinical Research |
author_facet |
Dejanov Petar Dejanova Beti |
author_sort |
Dejanov Petar |
title |
Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease |
title_short |
Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease |
title_full |
Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease |
title_fullStr |
Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease |
title_full_unstemmed |
Appropriate Biomarkers For Oxidative Stress In Patients With End Stage Renal Disease |
title_sort |
appropriate biomarkers for oxidative stress in patients with end stage renal disease |
publisher |
Sciendo |
series |
Serbian Journal of Experimental and Clinical Research |
issn |
1820-8665 2335-075X |
publishDate |
2015-12-01 |
description |
The appropriate biomarkers for oxidative stress (OS) in patients with end stage renal disease (ESRD) are important in renal pathology. Patients (56) with ESRD were investigated (35 men and 21 women). Patients, with mean age of 45±17 years, defined education, specific HD duration and calculated body mass index (BMI), were exposed to a polysulphone type HD membrane for approximately 4 hours per HD session, 3 times per week. The control group was composed of 31 healthy volunteers. The total antioxidative capacity (TAC) and the antioxidative (AO) enzymes superoxide dismutase (SOD) and glutathione peroxidase (GPx), were assessed. Analyses included Randox Crumlin GB; lipid peroxidation (LP) using its end product, malonyldialdehyde (MDA) (fluorimetric); and a LDL-ox immunoassay (Biomedica gruppe, Vienna, Austria). The TAS was higher in ESRD patients before HD (1.63±0.1 mmol/L) compared to the control group (1.23±0.03 mmol/L). |
url |
http://www.degruyter.com/view/j/sjecr.2015.16.issue-4/sjecr-2015-0037/sjecr-2015-0037.xml?format=INT |
work_keys_str_mv |
AT dejanovpetar appropriatebiomarkersforoxidativestressinpatientswithendstagerenaldisease AT dejanovabeti appropriatebiomarkersforoxidativestressinpatientswithendstagerenaldisease |
_version_ |
1725851950263566336 |